Ignite Creation Date:
2025-12-24 @ 2:23 PM
Ignite Modification Date:
2026-01-18 @ 1:20 PM
Study NCT ID:
NCT07209059
Status:
RECRUITING
Last Update Posted:
2025-10-06
First Post:
2025-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma
Sponsor:
National Research Center for Hematology, Russia
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
HL-2025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None